RS
MXCT icon

R Squared’s MaxCyte MXCT Stock Holding History

R Squared’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.47K Buy
+12,060
New +$11.3K ﹤0.01% 473
2025
Q3 		– Sell
-10,300
Closed -$22.5K – 652
2025
Q2 		$22.5K Buy
+10,300
New +$24.9K 0.01% 439

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

R Squared's MXCT Position: Q1 2026 in Review

R Squared opened a new position in MaxCyte (MXCT) in Q1 2026: 12,060 shares worth $8.47K. The stake represents ﹤0.01% of the portfolio and ranks #473 among its holdings. This is a return to the name: R Squared previously reported a position in MXCT as recently as Q2 2025.

R Squared first reported a position in MXCT in Q2 2025 and has held it in 2 quarters since. The position peaked at $22.5K in Q2 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • R Squared held 12,060 shares of MaxCyte worth $8.47K as of Q1 2026.
  • MaxCyte was a new R Squared position in Q1 2026.
  • MaxCyte made up ﹤0.01% of R Squared's portfolio in Q1 2026, its #473 holding.
  • R Squared first reported a position in MaxCyte in Q2 2025 and has held it in 2 quarters since.
  • R Squared's MaxCyte position peaked at $22.5K in Q2 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.